Target intelligence / Profile preview

Histone deacetylase 4 mRNA 3'-untranslated region (HDAC4 mRNA 3'-UTR)

Target
HDAC4 mRNA 3'-UTR
Molecular classification
mRNA, Untranslated region, Regulatory RNA element
01

Overview

The Histone deacetylase 4 (HDAC4) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the HDAC4 transcript that governs the post-transcriptional expression of the HDAC4 protein (Chen et al., 2006, Nature Genetics). This region contains multiple binding sites for microRNAs (miRNAs), such as miR-1, miR-206, and miR-140, which act to repress HDAC4 translation or promote mRNA degradation (Williams et al., 2009, Science). HDAC4 itself is a Class IIa histone deacetylase that shuttles between the nucleus and cytoplasm, playing a pivotal role in chromatin remodeling, muscle differentiation, and neuronal survival. Dysregulation of the HDAC4 3'-UTR-mediated control is implicated in various pathologies, including Huntington's disease, where elevated HDAC4 levels contribute to neurotoxicity, and several cancers where loss of regulatory miRNAs leads to HDAC4 overexpression (Mielcarek et al., 2013, PLOS Biology; Sana et al., 2012, Journal of Translational Medicine). Consequently, the HDAC4 3'-UTR is an emerging therapeutic target for RNA-based interventions, including miRNA mimics and antisense oligonucleotides (ASOs), designed to modulate HDAC4 protein levels for treating neurodegenerative and oncological conditions. Targeting this region offers a more specific approach to modulating HDAC4 compared to broad-spectrum small molecule HDAC inhibitors, though challenges remain regarding delivery and off-target effects.

Other names
HDAC4 3'-UTRHDAC4 3-prime UTRHistone deacetylase 4 3-untranslated region
02

Mechanism of action

RNA interference and antisense-mediated degradation or translational inhibition

03

Biological functions

Post-transcriptional regulationmRNA stabilityTranslational repressionGene silencing
04

Disease associations

Huntington's diseaseCancerAmyotrophic lateral sclerosisCardiac hypertrophySkeletal muscle atrophy
05

Safety considerations

Off-target RNA bindingDelivery to the central nervous systemPotential for systemic toxicitySaturation of the RNAi machinery
06

Interacting drugs

miR-1 mimic

3 more in the full profile.

07

Biomarkers

HDAC4 protein levelsmiR-1 expressionmiR-206 expression

Beyond the preview

Go deeper on Histone deacetylase 4 mRNA 3'-untranslated region (HDAC4 mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone deacetylase 4 mRNA 3'-untranslated region (HDAC4 mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call